ARIANNE Corp is a Clinical Research Organization (CRO) headquartered in San Diego, (California, US), providing Clinical Research and Regulatory services worldwide to biotechnology and pharmaceutical companies. ARIANNE offers scientific expertise in clinical and non-clinical development, US and International regulatory expertise, and clinical operations. ARIANNE conducts clinical trials (Phases I to IV) in North America, Europe, Australia and emerging economies in Asia, South America and Africa. Today, these countries are among key destinations of clinical trial expansion and present the advantages of large naïve patient populations, fast patient enrollment, excellent patient retention, and highly trained as well as skilled medical professionals. ARIANNE’s commitment is to further drug development by adeptly working in today’s shifting environment. Our objective is to accelerate drug development by shortening the clinical development phase while offering the highest standard of the industry and according to regulatory (FDA, ICH) guidelines for Good Clinical Practices. In order to achieve this goal, we offer to our clients the ability to conduct clinical trials in countries that allow for rapid patient recruitment and retention while remaining very cost effective. In addition, we have recruited experienced regulatory personnel in all countries where we offer our services to ensure that all regulatory submissions are completed efficiently and effectively and to ensure we are constantly up to date with international government timelines and guidelines. As the interface between regulatory agencies and industry moves forward in technology and harmonization, we provide the personnel proficient in this ever-changing landscape. Our multi-national team is highly committed to the development of your product and we take full responsibility and accountability acting as an extension of your company. Such commitment translates into excellence and successful projects.